Signalisation de l'Invasion tumorale : P. Coopman


Béganton B, Coyaud E, Mangé A, Solassol J [New approaches for protein-protein interaction study]. Med Sci (Paris). 2019;35(3):223-231. doi:10.1051/medsci/2019035

Vendrell J, Senal R, Rouquette I, Quantin X, Pujol J-L, Bouidioua A, Godreuil S, Coyaud E, Brousset P Ultra-sensitive EGFRT790Mdetection as an independent prognostic marker for lung cancer patients harboring EGFRdel19mutations and treated with first-generation TKIs. Clin. Cancer Res.. Apr 01, 2019. doi:10.1158/1078-0432.CCR-18-2683

D'Hondt V, Canon J-L, Roca L, Levy C, Pierga J-Y, Le Du F, Campone M, Desmoulins I, Goncalves A, Debled M, Rios M, Ferrero J-M, Serin D, Hardy-Bessard A-C, Piot G, Brain E, Dohollou N, Orfeuvre H, Roché H, Delaloge S, Dalenc F UCBG 2-04: Long-term results of the PACS 04 trial evaluating adjuvant epirubicin plus docetaxel in node-positive breast cancer and trastuzumab in the human epidermal growth factor receptor 2-positive subgroup. Eur. J. Cancer. 2019;122. doi:10.1016/j.ejca.2019.09.014

Tümmler C, Dumitriu G, Wickström M, Coopman P, Valkov A, Kogner P, Johnsen J, Moens U, Sveinbjörnsson B SYK Inhibition Potentiates the Effect of Chemotherapeutic Drugs on Neuroblastoma Cells in Vitro. Cancers (Basel). 2019;11(2). doi:10.3390/cancers11020202

Lacombe J, Brengues M, Mangé A, Bourgier C, Gourgou S, Pèlegrin A, Ozsahin M, Solassol J, Azria D Quantitative proteomic analysis reveals AK2 as potential biomarker for late normal tissue radiotoxicity. Radiat Oncol. 2019;14(1):142. doi:10.1186/s13014-019-1351-8

Alegre N, Perre P, Bignon Y, Michel A, Galibert V, Mophawe O, Corsini C, Coupier I, Chiesa J, Robert L, Bernhard L, Picot M-C, Bertet H, Macioce V, Bastide N, Solassol J, Rey J, Thomas F, Carton S, Pujol P Psychosocial and clinical factors of probands impacting intrafamilial disclosure and uptake of genetic testing among families with BRCA1/2 or MMR gene mutations. Psychooncology. Jun 01, 2019. doi:10.1002/pon.5142

Béganton B, Solassol I, Mangé A, Solassol J Protein interactions study through proximity-labeling. Expert Rev Proteomics. Jul 04, 2019. doi:10.1080/14789450.2019.1638769

Buffard M, Naldi A, Radulescu O, Coopman P, Larive R, Freiss G Network reconstruction and Significant Pathway Extraction Using Phosphoproteomic Data From Cancer Cells. Proteomics. Aug 31, 2019. doi:10.1002/pmic.201800450

Escudié F, Van Goethem C, Grand D, Vendrell J, Vigier A, Brousset P, Evrard S, Solassol J, Selves J MIAmS: microsatellite instability detection on NGS amplicons data. Bioinformatics. Oct 24, 2019. doi:10.1093/bioinformatics/btz797

Mangé A, Coyaud E, Desmetz C, laurent E, Béganton B, Coopman P, Raught B, Solassol J FKBP4 connects mTORC2 and PI3K to activate the PDK1/Akt-dependent cell proliferation signaling in breast cancer. 2019-8-11.

Solassol J, Vendrell J, Senal R, Audran P, Leenhardt F, Quantin X Challenging BRAF/EGFR co-inhibition in NSCLC using sequential liquid biopsies. Lung Cancer. 2019;133. doi:10.1016/j.lungcan.2019.05.003

Le Saux O, Lardy-Cleaud A, Frank S, Debled M, Cottu P, Pistilli B, Vanlemmens L, Leheurteur M, Laborde L, Uwer L, Berchery D, Lorgis V, Ferrero J-M, Courtinard C, Mouret-Reynier M, Velten M, Breton M, Parent D, Chabaud S, Robain M, Bachelot T Assessment of the efficacy of successive endocrine therapies in hormone receptor-positive and HER2-negative metastatic breast cancer: a real-life multicentre national study. Eur. J. Cancer. 2019;118. doi:10.1016/j.ejca.2019.06.014

Solassol J, Larrieux M, Leclerc J, Ducros V, Corsini C, Pujol P, Rey J-M Alu element insertion in the MLH1 exon 6 coding sequence as a mutation predisposing to Lynch syndrome. Hum. Mutat.. Feb 28, 2019. doi:10.1002/humu.23725

Jacot W, Cottu P, Berger F, Dubot C, Venat-Bouvet L, Lortholary A, Bourgeois H, Bollet M, Luporsi E, Sablin M-P, Brain E, Neffati S, Pierga J-Y Actionability of HER2-amplified circulating tumor cells in HER2-negative metastatic breast cancer: the CirCe T-DM1 trial. Breast Cancer Res.. 2019;21(1):121. doi:10.1186/s13058-019-1215-z

Godreuil S, Marcy O, Wobudeya E, Bonnet M, Solassol J Tackling mortality due to childhood tuberculosis. Lancet Public Health. 2018;3(4):e165. doi:10.1016/S2468-2667(18)30049-5

Beziaud L, Boullerot L, Tran T, Mansi L, Marie-Joseph E, Ravel P, Johannes L, Bayry J, Tartour E, Adotévi O Rapalog combined with CCR4 antagonist improves anticancer vaccines efficacy. Int. J. Cancer. 2018;143(11):3008-3018. doi:10.1002/ijc.31842

Oza A, Matulonis U, Malander S, Hudgens S, Sehouli J, Del Campo J, Berton-Rigaud D, Banerjee S, Scambia G, Berek J, Lund B, Tinker A, Hilpert F, Vázquez I, D'Hondt V, Benigno B, Provencher D, Buscema J, Agarwal S, Mirza M Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA): results from a double-blind, phase 3, randomised controlled trial. Lancet Oncol.. 2018;19(8):1117-1125. doi:10.1016/S1470-2045(18)30333-4

Bhardwaj D, Náger M, Visa A, Sallán M, Coopman P, Cantí C, Herreros J Phosphorylated Tyr142 ?-catenin localizes to centrosomes and is regulated by Syk. J. Cell. Biochem.. 2018;119(4):3632-3640. doi:10.1002/jcb.26571

Bessis D, Petit A, Battistella M, Bourrat E, Girard C, Pallure V, Marque M, Lacour J-P, Vitetta A, Bieth É, Selves J, Solassol J, Vendrell J Naevoid acanthosis nigricans or RAVEN (rounded and velvety epidermal naevus) and mosaic FGFR3 and FGFR2 mutations. Br. J. Dermatol.. Dec 22, 2018. doi:10.1111/bjd.17581

Cottu P, D'Hondt V, Dureau S, Lerebours F, Desmoulins I, Heudel P-E, Duhoux F, Levy C, Mouret-Reynier M-A, Dalenc F, Frenel J-S, Jouannaud C, Venat-Bouvet L, Nguyen S, Ferrero J-M, Canon J-L, Grenier J, Callens C, Gentien D, Lemonnier J, Vincent-Salomon A, Delaloge S Letrozole and palbociclib versus chemotherapy as neoadjuvant therapy of high-risk luminal breast cancer. Ann. Oncol.. Oct 11, 2018. doi:10.1093/annonc/mdy448

Vendrell J, Solassol J, Gy?rffy B, Vilquin P, Jarlier M, Donini C, Gamba L, Maudelonde T, Rouanet P, Cohen P Evaluating ZNF217 mRNA Expression Levels as a Predictor of Response to Endocrine Therapy in ER+ Breast Cancer. Front Pharmacol. 2018;9. doi:10.3389/fphar.2018.01581

Solassol J, Quantin X, Larrieux M, Senal R, Audran P, Grand D, Mangé A, Diamandis E, Vendrell J Comparison of five cell-free DNA isolation methods to detect the EGFR T790M mutation in plasma samples of patients with lung cancer. Clin. Chem. Lab. Med.. 2018;56(9):e243-e246. doi:10.1515/cclm-2017-0967

Vendrell J, Vilquin P, Larrieux M, Van Goethem C, Solassol J Benchmarking of Amplicon-Based Next-Generation Sequencing Panels Combined with Bioinformatics Solutions for Germline BRCA1 and BRCA2 Alteration Detection. J Mol Diagn. 2018;20(6):754-764. doi:10.1016/j.jmoldx.2018.06.003

Vittecoq M, Laurens C, Brazier L, Durand P, Elguero E, Arnal A, Thomas F, Aberkane S, Renaud N, Prugnolle F, Solassol J, Jean-Pierre H, Godreuil S, Renaud F VIM-1 carbapenemase-producing Escherichia coli in gulls from southern France. Ecology and evolution. 2017;7. doi:10.1002/ece3.2707

Leconet W, Chentouf M, du Manoir S, Chevalier C, Sirvent A, Aït-Arsa I, Busson M, Jarlier M, Radosevic-Robin N, Theillet C, Chalbos D, Pasquet J-M, Pèlegrin A, Larbouret C, Robert B Therapeutic Activity of Anti-AXL Antibody against Triple-Negative Breast Cancer Patient-Derived Xenografts and Metastasis. 2017;23(11):2806-2816. doi:10.1158/1078-0432.CCR-16-1316

© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés